We adhere strictly to the best practices established by the pharmaceutical industry standards. Crucially, our associates originate from the specialized Business Development & Licensing sector of the industry. We boast a comprehensive suite of proprietary research and best-practice ‘Deal Tools’, fortified by extensive tenure with multinational corporations. Our global reach extends to every corner of the world, underpinned by an international culture and unparalleled expertise. Armed with deep-rooted industry knowledge and an extensive network of senior-level contacts spanning the globe, we stand ready to facilitate your success.
Certain companies possess products necessitating additional development or commercialization support. A deal not only bestows validation but also provides vital resources and funding. Across the spectrum, both large enterprises and smaller entities seek novel products. Spearheading these crucial transactions are Business Development executives, orchestrating the process until its successful culmination. Our role encompasses product identification for licensing, procurement of corporate partners for licensing arrangements, strategic planning, and meticulous preparation of transactional documentation.
Whether earmarked for investment or integral to a corporate transaction, due diligence stands as an indispensable facet of the process. This comprehensive scrutiny encompasses both commercial and technical dimensions. Technical due diligence encompasses meticulous patent assessments, scientific data analysis, competitive landscape evaluation, development trajectory scrutiny, manufacturing assessment, and related areas. Concurrently, commercial due diligence aligns closely with financial and market analyses, sales and profit forecasting, risk-sensitivity analysis with robust assumptions, and comprehensive valuations.
While a limited number of large enterprises achieve genuine global reach, numerous companies attain success through product marketing within their domestic or regional spheres. However, expanding infrastructure into additional markets often presents a formidable challenge. Leveraging our extensive network of affiliations with licensees and distributors worldwide, we offer a seamless pathway for geographical expansion. This strategic collaboration facilitates the introduction of innovative healthcare products into new markets, thereby providing companies seeking expansion with a tailored solution.
Comprising seasoned industry experts who have held senior roles, our team brings forth a wealth of experience, coupled with an expansive network within the pharmaceutical, biotech, and investment sectors. Our approach is meticulously tailored to address your unique requirements, ensuring precision and efficacy in our collaborative endeavors.
Our ethos encapsulates innovation, creativity, steadfast support, and unwavering delivery
Our commercial operations are based on our network of regional and national distributors, that are experts in the supply of health products, capable of delivering the products to the consumers through the supply chain.
While few and very large healthcare companies are truly vertical, the sector has many small to midsize companies that require in and out licensing and research and development along with infrastructure assistance.
We have a large network of links with pharmaceutical companies and distributors around the world that facilitate introducing novel products to the markets.
While Europe is the region with advanced healthcare systems, we help to identify available products in those countries that can provide an additional opportunity for licensing or development in the USA.
© 2024 Ashbury Capital, LLC, | All rights reserved.
DUNS Number: 080676671